Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Genes Cells ; 26(1): 5-17, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33098150

RESUMEN

c-Jun N-terminal kinases (JNKs) are constitutively activated in mammalian brains and are indispensable for their development and neural functions. MKK7 is an upstream activator of all JNKs. However, whether the common JNK signaling pathway regulates the brain's control of social behavior remains unclear. Here, we show that female mice in which Mkk7 is deleted specifically in mature neurons (Mkk7flox/flox Syn-Cre mice) give birth to a normal number of pups but fail to raise them due to a defect in pup retrieval. To explore the mechanism underlying this abnormality, we performed comprehensive behavioral tests. Mkk7flox/flox Syn-Cre mice showed normal locomotor functions and cognitive ability but exhibited depression-like behavior. cDNA microarray analysis of mutant brain revealed an altered gene expression pattern. Quantitative RT-PCR analysis demonstrated that mRNA expression levels of genes related to neural signaling pathways and a calcium channel were significantly different from controls. In addition, loss of neural MKK7 had unexpected regulatory effects on gene expression patterns in oligodendrocytes. These findings indicate that MKK7 has an important role in regulating the gene expression patterns responsible for promoting normal social behavior and staving off depression.


Asunto(s)
MAP Quinasa Quinasa 7/metabolismo , Conducta Materna , Neuronas/metabolismo , Animales , Conducta Animal , Femenino , MAP Quinasa Quinasa 7/deficiencia , MAP Quinasa Quinasa 7/genética , Ratones , Ratones Endogámicos C57BL , Oligodendroglía/metabolismo
2.
Psychopharmacology (Berl) ; 234(2): 293-305, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27774567

RESUMEN

RATIONALE: Members of the c-Jun N-terminal kinase (JNK) family of mitogen-activated protein (MAP) kinases, and the upstream kinase MKK7, have all been strongly linked with synaptic plasticity and with the development of the neocortex. However, the impact of disruption of this pathway on cognitive function is unclear. OBJECTIVE: In the current study, we test the hypothesis that reduced MKK7 expression is sufficient to cause cognitive impairment. METHODS: Attentional function in mice haploinsufficient for Map2k7 (Map2k7 +/- mice) was investigated using the five-choice serial reaction time task (5-CSRTT). RESULTS: Once stable performance had been achieved, Map2k7 +/- mice showed a distinctive attentional deficit, in the form of an increased number of missed responses, accompanied by a more pronounced decrement in performance over time and elevated intra-individual reaction time variability. When performance was reassessed after administration of minocycline-a tetracycline antibiotic currently showing promise for the improvement of attentional deficits in patients with schizophrenia-signs of improvement in attentional performance were detected. CONCLUSIONS: Overall, Map2k7 haploinsufficiency causes a distinctive pattern of cognitive impairment strongly suggestive of an inability to sustain attention, in accordance with those seen in psychiatric patients carrying out similar tasks. This may be important for understanding the mechanisms of cognitive dysfunction in clinical populations and highlights the possibility of treating some of these deficits with minocycline.


Asunto(s)
Atención/fisiología , Cognición/fisiología , Haploinsuficiencia/genética , MAP Quinasa Quinasa 7/genética , Minociclina/farmacología , Esquizofrenia/genética , Animales , Atención/efectos de los fármacos , Conducta de Elección/efectos de los fármacos , Conducta de Elección/fisiología , Cognición/efectos de los fármacos , Femenino , Humanos , MAP Quinasa Quinasa 7/deficiencia , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Minociclina/uso terapéutico , Tiempo de Reacción/efectos de los fármacos , Tiempo de Reacción/genética , Factores de Riesgo , Esquizofrenia/tratamiento farmacológico
3.
J Biochem ; 145(3): 345-54, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19106158

RESUMEN

SP600125 is used as a specific inhibitor of c-Jun N-terminal kinase (JNK). We initially aimed to examine physiological roles of JNK in mast cells that play a central role in inflammatory and immediate allergic responses. We found that Fc receptor for IgE (FcepsilonRI)-induced degranulation (serotonin release) and cytokine gene expression [interleukin (IL)-6, tumour necrosis factor-alpha and IL-13] in bone marrow-derived mast cells, were almost completely inhibited by SP600125. However, the time course of FcepsilonRI-induced JNK activation did not correlate with that of serotonin release. Furthermore, FcepsilonRI-induced degranulation and cytokine gene expression were not impaired in a JNK activator, MKK7-deficient mast cells, in which JNK activation was lost. These results indicate that the inhibitory effects by SP600125 are not due to impaired JNK activation. Instead, we found that SP600125 markedly inhibited the FcepsilonRI-induced activation of phosphatidylinositol 3-kinase (PI3K) and Akt, the same as a PI3K inhibitor, wortmannin. Finally, we found that SP600125 specifically inhibits delta form of p110 catalytic subunit (p110delta) of PI3K. Thus, SP600125 exerts its influence on mast cell functions by inhibiting the kinase activity of PI3K, but not JNK.


Asunto(s)
Antracenos/farmacología , Degranulación de la Célula/efectos de los fármacos , Citocinas/genética , Mastocitos/enzimología , Inhibidores de las Quinasa Fosfoinosítidos-3 , Receptores de IgE/metabolismo , Transducción de Señal/efectos de los fármacos , Animales , Células de la Médula Ósea/citología , Células de la Médula Ósea/efectos de los fármacos , Células de la Médula Ósea/enzimología , Señalización del Calcio/efectos de los fármacos , Fosfatidilinositol 3-Quinasa Clase I , Citocinas/metabolismo , Activación Enzimática/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Isoenzimas/metabolismo , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , MAP Quinasa Quinasa 7/deficiencia , MAP Quinasa Quinasa 7/metabolismo , Mastocitos/efectos de los fármacos , Mastocitos/fisiología , Ratones , Proteínas Tirosina Quinasas/metabolismo , Receptores Purinérgicos P1/metabolismo , Quinasa Syk , Familia-src Quinasas/metabolismo
4.
J Cell Biochem ; 104(5): 1771-80, 2008 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-18348256

RESUMEN

JNK, a member of the mitogen-activated protein kinases (MAPKs), is activated by the MAPK kinases SEK1 and MKK7 in response to environmental stresses. In the present study, the effects of CdCl2 treatment on MAPK phosphorylation and HSP70 expression were examined in mouse embryonic stem (ES) cells lacking the sek1 gene, the mkk7 gene, or both. Following CdCl2 exposure, the phosphorylation of JNK, p38, and ERK was suppressed in sek1-/- mkk7-/- cells. When sek1-/- or mkk7-/- cells were treated with CdCl2, JNK phosphorylation, but not the phosphorylation of either p38 or ERK, was markedly reduced, while a weak reduction in p38 phosphorylation was observed in sek1-/- cells. Thus, both SEK1 and MKK7 are required for JNK phosphorylation, whereas their role in p38 and ERK phosphorylation could overlap with that of another kinase. We also observed that CdCl2-induced HSP70 expression was abolished in sek1-/- mkk7-/- cells, was reduced in sek1-/- cells, and was enhanced in mkk7-/- cells. Similarly, the phosphorylation of heat shock factor 1 (HSF1) was decreased in sek1-/- mkk7-/- and sek1-/- cells, but was increased in mkk7-/- cells. Transfection with siRNA specific for JNK1, JNK2, p38, ERK1, or ERK2 suppressed CdCl2-induced HSP70 expression. In contrast, silencing of p38 or p38 resulted in further accumulation of HSP70 protein. These results suggest that HSP70 expression is up-regulated by SEK1 and down-regulated by MKK7 through distinct MAPK isoforms in mouse ES cells treated with CdCl2.


Asunto(s)
Cloruro de Cadmio/toxicidad , Células Madre Embrionarias/efectos de los fármacos , Células Madre Embrionarias/enzimología , Proteínas HSP70 de Choque Térmico/metabolismo , MAP Quinasa Quinasa 4/metabolismo , MAP Quinasa Quinasa 7/metabolismo , Animales , Línea Celular , Proteínas de Unión al ADN/metabolismo , Factores de Transcripción del Choque Térmico , Respuesta al Choque Térmico/efectos de los fármacos , Isoenzimas/metabolismo , MAP Quinasa Quinasa 4/deficiencia , MAP Quinasa Quinasa 7/deficiencia , Ratones , Fosforilación/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Factores de Transcripción/metabolismo
5.
Biochim Biophys Acta ; 1773(8): 1349-57, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17157936

RESUMEN

c-Jun NH2-terminal protein kinase (JNK) is a mitogen-activated protein kinase (MAPK) involved in the regulation of numerous physiological processes during development and in response to stress. Its activity is increased upon phosphorylation by the MAPK kinases, MKK4 and MKK7. Similar to the early embryonic death of mice caused by the targeted deletion of the jnk genes, mice lacking mkk4 or mkk7 die before birth. The inability of MKK4 and MKK7 to compensate for each other's functions in vivo is consistent with their synergistic effect in mediating JNK activation. However, the phenotypic analysis of the mutant mouse embryos indicates that MKK4 and MKK7 have specific roles that may be due to their selective regulation by extracellular stimuli and their distinct tissue distribution. MKK4 and MKK7 also have different biochemical properties. For example, whereas MKK4 can activate p38 MAPK, MKK7 functions as a specific activator of JNK. Here we summarize the studies that have shed light on the mechanism of activation of MKK4 and MKK7 and on their physiological functions.


Asunto(s)
MAP Quinasa Quinasa 4/fisiología , MAP Quinasa Quinasa 7/fisiología , Secuencia de Aminoácidos , Animales , Apoptosis , Clonación Molecular , Femenino , Cardiopatías/enzimología , Sistema Inmunológico/enzimología , Hígado/enzimología , MAP Quinasa Quinasa 4/deficiencia , MAP Quinasa Quinasa 4/genética , MAP Quinasa Quinasa 7/deficiencia , MAP Quinasa Quinasa 7/genética , Ratones , Ratones Noqueados , Modelos Animales , Datos de Secuencia Molecular , Neoplasias/enzimología , Neuronas/citología , Neuronas/enzimología , Embarazo , Distribución Tisular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA